Tividenofusp alfa

替艾芙普α

Report date: 2026/04/27 20:02:09

Base Information

Drug NameTividenofusp alfa
Drug Alias NameAVLAYAHDNL-310ETV:IDS
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionIduronate-2-sulfatase replacements
TargetsIduronate-2-sulfatase
Therapy Area/IndicationsMucopolysaccharidosis II
Global Approved IndicationsMucopolysaccharidosis II
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2026/03/24
Country/TerritoryCzechiaBelgiumCanada +[15
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesDenali Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesDenali Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMucopolysaccharidosis II
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksDrugBankKEGG